期刊文献+

第三代毒品——新精神活性物质(NPS)发展趋势评估、管制瓶颈与应对策略 被引量:20

On the Growing Trend Assessment, Bottleneck of Regulation and Countermeasure of NPS, the Third Generation Drug
下载PDF
导出
摘要 第三代毒品——新精神活性物质(NPS)的不断蔓延扩散,已经对社会治安和公共卫生造成不容忽视的现实危害,也使得毒品治理这一世界性难题变得更加复杂艰难,亟待正视。目前第三代毒品的趋势有以下几特点:种类繁多、变异迅猛;个性定制、产销两旺;认知度低,受众广泛;网络传播、形式隐秘;危害频现、影响恶劣。管制的瓶颈主要表现在:立法滞后,列管迟钝;打击乏力、综治滞后;宣传失准、导向偏差。应从健全立法,弥补漏洞;强化综治,形成机制;有的放矢,重点突破;加强协作,形成合力等方面进行应对。 The spreading of new psychoactivc substance (NPS), the third generation drug, has done unncgligiblc harmto social order and public health and made drug control more complicated, which demands serious attention. The featuresof its growing trend includes great variety, swift and violent variation, custom made, thrive production and marketing, lowcognition degree, extensive receivers, secret network communication and with frequent harms and bad influence. Thebottlenecks of regulation involve lagging legislation and comprehensive treatment, inertial administration, weak strike,inaccurate publicity and deviated orientation. The following countermeasures are recommended: perfecting the legislation topatch the leak, strengthening comprehensive treatment to form mechanism, having a definite object to make majorbreakthrough and strengthening cooperation to make concerted efforts.
出处 《四川警察学院学报》 2017年第1期97-102,共6页 Journal of Sichuan Police College
关键词 第三代毒品 趋势评估 管制瓶颈 应对策略 The Third Generation Growing Trend Assessment Bottleneck of Regulation Countermeasure
  • 相关文献

参考文献6

二级参考文献46

  • 1McElrath K, O' Neill, C. Experiences with Mephedrone pre- and post-legislative controls: Perceptions of safety and sources of supply. International Journal of Drug Policy,2011,22 (2) : 120-127.
  • 2"Europol-EMCDDA Joint Report on a new psychoactive substance: 4-methylmethcathinone ( Mephedrone ) ". European Monitoring Centre for Drugs and Drug Addiction. 27 May 2010.
  • 3Winstock A, Marsden, J, Mitcheson, L. What should be done about Mephedrone?. British Medical Journal, 2010 Mar 23,340 : e1605.
  • 4James D, Adams R, Spears R, et al. Clinical characteristics of Mephedrone toxicity reported to the UK National Poisons Information Service. Emergency medicine journal, emj ,2010. 095636.
  • 5Nicholson P, Quinn M, Dodd J. Headshop heartache: acute Mephedrone 'meow' myocarditis. British Medical Journal: Heart 96, 2010, (24) : 2051-2.
  • 6Camilleri A,Johnston,M, Brennan M, et al. Chemical analysis of four capsules containing the controlled substance analogues 4- methylmethcathinone, 2-fluoromethamphetamine, alpha-phthalimidopropiophenone and N-ethylcathinone. Forensic Science International, 2010, 197 (1-3): 59-66.
  • 7Meyer M, Wilhelm J, Peters F, et al; Beta-keto amphetamines: studies on the metabolism of the designer drug Mephedrone and toxicological detection of Mephedrone, butylone, and methylone in urine using gas chromatography-mass spectrometry. Analytical and Bioanalytical Chemistry, 2010, 397 (3): 1225-1233.
  • 8Wood D M, Davies S, Puchrtarewicz M, et al. Recreational Use of Mephedrone (4-Methylmethcathinone, 4-MMC) with Associated Sympathomimetic Toxicity. Journal of Medical Toxicology, 2010,6 (3) : 327-330.
  • 9Torrance H, Cooper G. The detection of Mephedrone (4-methyl-metheathinone) in 4 fatalities in Seotland. Forensie Seienee International, 2010, 202 ( 1 ) : e62-e63.
  • 10Past A,Vorce S, Levine B,et al. Case report : multiple-drug toxicity caused by the coadministration of 4-methylmethcathinone (Mephedrone) and heroin. Journal of Analytical Toxicology,2010, 34 (3):162-168.

共引文献48

同被引文献137

引证文献20

二级引证文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部